Received Nov 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y018677 | — |
zero patients who received the affected administered doses reported any adverse issues or side effects; Caller provided the following temperature excursion information and patient information that received PEDVAX HIB after temperature excursion; This spontaneous report was received from nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. Multiple temperature excursion was reported (12-SEP-2025, 8.9 C for 15 minutes; 24-SEP-2025, 8.4 C for 8 minutes; 25-SEP-2025, 8.2 C for 12 minutes). On 01-Oct-2025, the patient was vaccinated with an improperly storage dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PEDVAX HIB) (Lot Number: Y018677) (Expiration date: 10-Apr-2027) (strength, dose, frequency, and anatomical location not provided) for prophylaxis (Product storage error). Reporter stated that zero patients who received the affected administered doses reported any adverse issues or side effects This is one of several reports form the same reporter.